WHO to promote second line anti-TB drugs production
The anti-TB drugs market is set to witness some action in the near future with the World Health Organization (WHO) proposing more programmes to promote second line drugs production.

HLL acquisition of KSDPL to be finalised next month
The acquisition of the public state undertaking Kerala State Drugs and Pharmaceuticals Ltd (KSDPL) by Asia’s largest contraceptive manufacturer Hindustan Latex Ltd (HLL) will be decided next month, informed R Rajagopal, managing director, KSDPL.

Govt may review IP Commission to empower scientific committee
The government may make minor structural changes to the constitution of the governing body of the Indian Pharmacopoeia (IP) Commission and empower the scientific committee. This is following representation from stakeholders including the IP Committee members.